facebook
spears_logo

Top Recommended
Click to explore ranking

tatler_logo

Featured in
The Tatler Address Book

doctify_logo

Outstanding
Click to see reviews

spears_logo
tatler_logo
doctify_logo

How common is posterior capsule opacification?

3 min read

Posterior capsule opacification (PCO) is the most common long-term complication of cataract surgery. Incidence rates vary widely depending on the definition used (clinically visible PCO versus visually significant PCO requiring treatment), the design of the intraocular lens implanted, surgical technique, patient demographics, and duration of follow-up. ¹

Systematic reviews estimate that visually significant PCO, defined as opacification sufficient to reduce best-corrected visual acuity to 20/50 or worse, occurs in approximately 20% to 40% of patients within five years of cataract surgery. ¹ However, clinically detectable PCO, which may not yet affect vision, can be present in up to 50% of patients during the same timeframe. Rates are substantially higher in children and young adults, with paediatric populations experiencing PCO rates exceeding 50% within two years due to more aggressive lens epithelial cell proliferation. ³

The introduction of modern hydrophobic acrylic intraocular lenses with sharp, square posterior optic edges has significantly reduced PCO rates compared to earlier lens designs. ² Studies comparing older polymethylmethacrylate (PMMA) and hydrophilic acrylic lenses to contemporary hydrophobic acrylic designs show reductions in YAG capsulotomy rates from 30-40% at five years to 10-15% with newer lenses. ²

Patient-related risk factors for higher PCO rates include younger age, diabetes mellitus, uveitis, retinitis pigmentosa, and myotonic dystrophy. ³ Surgical factors associated with increased PCO include incomplete cortical cleanup, retained lens epithelial cells, and surgical complications. Despite these variables, PCO remains a frequent occurrence, making YAG laser capsulotomy one of the most commonly performed ophthalmic laser procedures worldwide.

References

  1. Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998;105(7):1213-1221.
  2. Findl O, Buehl W, Bauer P, Sycha T. Interventions for preventing posterior capsule opacification. Cochrane Database of Systematic Reviews. 2010;(2):CD003738.
  3. Raj SM, Vasavada AR, Johar SR, Vasavada VA, Vasavada VA. Post-operative capsular opacification: a review. International Journal of Biomedical Science. 2007;3(4):237-250.

Related Topics

Return to Knowledge Base

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.